Expert Highlights Practice-Changing Effects of Immunotherapies in Multiple Myeloma

Transcript:

Immunotherapies—meaning bispecifics and CAR T—are going to change the way we take care of our disease. We need to figure out how to make sure all patients will have access to these novel therapies, these novel immunotherapies, or these T cell–engaging therapies. We’re on the horizon of understanding what they mean clinically, and how they work in the context of the immune microenvironment.

Transcript edited for clarity.